Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity  by Azzeh, Maysa et al.
06) 69–79
www.elsevier.com/locate/yviroVirology 354 (20Structural changes in human cytomegalovirus cytoplasmic assembly sites in
the absence of UL97 kinase activity
Maysa Azzeh a,b,1, Alik Honigman b, Albert Taraboulos c, Alexander Rouvinski c, Dana G. Wolf a,⁎
a Department of Clinical Microbiology and Infectious Diseases, Hadassah University Hospital, Jerusalem, Israel 91120
b Department of Virology, the Hebrew University-Hadassah Medical School, Jerusalem, Israel
c Molecular Biology, the Hebrew University-Hadassah Medical School, Jerusalem, Israel
Received 15 February 2006; returned to author for revision 17 May 2006; accepted 31 May 2006
Available online 26 July 2006Abstract
Studies of human cytomegalovirus (HCMV) UL97 kinase deletion mutant (ΔUL97) indicated a multi-step role for this kinase in early and late
phases of the viral life cycle, namely, in DNA replication, capsid maturation and nuclear egress. Here, we addressed its possible involvement in
cytoplasmic steps of HCMVassembly. Using the ΔUL97 and the UL97 kinase inhibitor NGIC-I, we demonstrate that the absence of UL97 kinase
activity results in a modified subcellular distribution of the viral structural protein assembly sites, from compact structures impacting upon the
nucleus to diffuse perinuclear structures punctuated by large vacuoles. Infection by either wild type or ΔUL97 viruses induced a profound
reorganization of wheat germ agglutinin (WGA)-positive Golgi-related structures. Importantly, the viral-induced Golgi remodeling along with the
reorganization of the nuclear architecture was substantially altered in the absence of UL97 kinase activity. These findings suggest that UL97
kinase activity might contribute to organization of the viral cytoplasmic assembly sites.
© 2006 Elsevier Inc. All rights reserved.Keywords: UL97 kinase; Cytoplasmic assembly sites; Pp28Introduction
Human cytomegalovirus (HCMV), a betaherpesvirus, is a
major cause of disease in immunocompromised individuals
including AIDS patients and transplant recipients and a
common cause of congenital infection leading to developmental
abnormalities and hearing loss (Pass, 2001).
The HCMV virion consists of a DNA containing capsid, a
tegument layer and a lipid envelope (Gibson, 1996; Mocarski
and Tan Courcelle, 2001). During capsid maturation in the
nucleus, large concatemeric DNA intermediates are cleaved to
genome-length units and packaged into preformed capsids via
the DNA packaging machinery (Gibson, 1996; Mocarski and
Tan Courcelle, 2001). DNA packaging into capsid precursors
displaces a scaffold structure to yield C capsids that further⁎ Corresponding author. Fax: +972 2 6427921.
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Mocarski and Tan Courcelle, 2001). Subsequent events during
nuclear egress and viral assembly have remained controversial.
The current model suggests that assembled nucleocapsids bud
through the inner nuclear membrane, acquiring an initial
envelope layer (Mettenleiter, 2002; Mocarski and Tan Cour-
celle, 2001). Subsequent shuttling into the cytoplasm involves
deenvelopment and budding of nucleocapsids into trans-Golgi-
related vesicles regarded as the viral assembly sites, where final
tegumentation and secondary envelopment occur (Gershon et
al., 1994; Homman-Loudiyi et al., 2003; Jarvis et al., 2004;
Mettenleiter, 2002; Muranyi et al., 2002; Sanchez et al., 2000a,
2000b; Skepper et al., 2001). Although several lines of evidence
support this model, studies in HCMV are limited, and the viral
and cellular mechanisms which govern nuclear egress, tegu-
ment trafficking and envelopment are currently unknown.
The UL97 gene product is the only well-established HCMV-
encoded protein kinase (Chee et al., 1989; He et al., 1997;
Michel et al., 1999; Michel and Mertens, 2004; van Zeijl et al.,
1997). This unusual serine/threonine protein kinase was
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major antiviral nucleoside analog ganciclovir, thus mediating its
antiviral activity (Littler et al., 1992; Sullivan et al., 1992).
Furthermore, mutations in the UL97 kinase domain, character-
ized by us and by others, lead to clinical ganciclovir resistance
(Chou et al., 1995; Wolf et al., 1995). The UL97 kinase is highly
conserved in all herpesviruses (Chee et al., 1989). The
alphaherpesvirus homologs of UL97, the herpes simplex virus
(HSV) UL13 and the varicella zoster virus (VZV) ORF47, have
been shown to phosphorylate viral immediate early proteins and
cellular proteins (Kawaguchi et al., 1999; Moffat et al., 1998; Ng
et al., 1994; Purves et al., 1993) and, although proven non-
essential for replication in cell culture, have been implicated in
regulation of viral gene expression and tissue tropism (Kawa-
guchi et al., 1999; Moffat et al., 1998; Ng et al., 1994; Purves et
al., 1993). In HCMV, the UL97 kinase plays a crucial role in viral
propagation, and a UL97 deletion mutation results in a 2–3-log
reduction in viral yield (Prichard et al., 1999). Moreover, the
UL97 kinase has been shown to be the target of maribavir, a new
potent and selective antiviral drug (Biron et al., 2002). Our
previous studies of a replication deficient UL97 deletion mutant
show a complex multi-step role of UL97 kinase in both early and
late steps of the viral life cycle, namely, in pre-elongation step of
DNA synthesis, DNA encapsidation, capsid maturation and
nuclear egress (Wolf et al., 2001). Other studies implicated more
specifically the involvement of UL97 in either DNA synthesis or
nuclear egress (Biron et al., 2002; Krosky et al., 2003a, 2003b).
Additionally, the UL97 has been shown to phosphorylate the
viral DNA polymerase processivity factor UL44 (Krosky et al.,
2003a, 2003b; Marschall et al., 2003) and to be involved in
phosphorylation of nuclear lamins (Marschall et al., 2005), to
mediate the intranuclear distribution of the tegument protein
pp65 (Prichard et al., 2005) and to play some role inmodification
of the RNA polymerase II in vitro (Baek et al., 2004).
The multiple roles played by UL97 in viral maturation
prompted us to address its possible involvement in cytoplasmic
steps of HCMV tegumentation and assembly. Using a UL97
deletion mutant and specific viral inhibitors, we demonstrate
that UL97 kinase activity is required for the proper subcellular
distribution of viral cytoplasmic assembly sites.
Results
Modified subcellular distribution of pp28 in cells infected with
the UL97 mutants (ΔUL97)
As a target for investigating the role of UL97 in HCMV
maturation and tegument protein trafficking, we chose the
abundant tegument protein UL99-encoded pp28, a late protein
that is expressed exclusively in the cytoplasm (Kerry et al.,
1997; Sanchez et al., 2000a, 2000b).
HF cells grown in 8-well slides were infected with either
AD169 or ΔUL97 at a MOI of 0.5. At 96 hpi, the cells were
stained with pp28 mAb, counterstained with propidium iodide
(PI) and analyzed by confocal immunofluorescence microscopy
(Fig. 1). Following infection of cells with wt-HCMV, pp28 was
found in a compact, juxtanuclear distribution in 95% (±2.6%) ofthe infected cells (Fig. 1A). These findings are in agreement
with the findings of Sanchez et al. (Sanchez et al., 2000a,
2000b). In contrast, following infection with each of theΔUL97
mutants, pp28 assumed a more diffuse, perinuclear distribution
observed in 86% (±7.8%) while only 14% assumed the compact
juxtanuclear structure. The pp28 stained regions were abun-
dantly punctuated by 2–8 μm wide vacuoles, not observed in
cells infected with the wild type virus (see Fig. 1B, ΔUL97,
arrows). Only the periphery of these vacuoles was stained by
pp28, whereas their interior was negative for both pp28 and PI.
These vacuoles were also clearly visible by Nomarski
microscopy (Fig. 1C, arrows). Vacuoles were also observed in
about 50% of the nuclei of the ΔUL97-infected cells (Fig. 1B,
yellow arrow). The periphery of these vacuoles was stained with
pp65 (data not shown). Similar changes were also found in the
cytoplasmic localization of the UL55-encoded glycoprotein B
(gB) (89% ± 1.5% compact structures in the wild type versus
10% ± 2% compact structures in the mutant; see Fig. 5B). The
vacuoles were not related to lipid droplets since their interior did
not stain with Nile red (not shown). In contrast to the tegument
and envelope proteins, the localization of the major capsid
protein was strictly nuclear in both wild type (as already
described by Lai and Britt, 2003) and mutant-infected cells and
was not modified in the absence of UL97 activity (data not
shown).
Wild type and mutant viruses also had a strikingly different
effect on the nuclear shape. While the nucleus of cells infected
with wt-HCMV was reproducibly deformed, assuming a kidney
shape (Fig. 1), no effect on the shape of the nucleus was noticed
following infection with ΔUL97. Identical findings were
observed following infection with the two independently
isolated deletion mutants RCΔ97.08 and RCΔ97.19 (Prichard
et al., 1999).
Membrane association of pp28
The pp28 membrane association dictates its cellular
localization and is believed to mediate its role in secondary
viral envelopment in the cytoplasm (Jones and Lee, 2004;
Sanchez et al., 2000a, 2000b; Silva et al., 2003). The modified
cellular localization of pp28 in cells infected with ΔUL97 virus
could reflect an altered membrane association of this tegument
protein. To examine the membrane association of pp28, we
carried out flotation assays using CHAPS as a detergent and
Nycodenz as a density medium. CHAPS is known to float many
membrane-associated proteins, whereas soluble proteins not
associated with membranes remain in the bottom of the gradient
(Rouvinski et al., 2003). In both wild type and mutant virus-
infected cells, pp28 partitioned in low density, CHAPS-
insoluble membrane complexes as revealed by Western blot
analysis (Fig. 2A). As controls for the flotation analysis, we
used monoclonal antibodies against calnexin, a known
membrane-associated protein (floating in CHAPS), and fumar-
ase, a non-membrane-associated protein (non-floating in
CHAPS) (Fig. 2A). While expression of pp28 was slightly
reduced (at most a 2 to 3 fold decrease) in the absence of UL97,
its relative abundance in the different flotation fractions,
Fig. 1. Cellular distribution of pp28 in HCMV-infected cells. Human foreskin fibroblasts were infected with either wt-HCMV (AD169, A–C) or UL97 deletion mutant
(ΔUL97, A–C) at an moi of 0.5 and prepared for immunofluorescence analysis at 96 hpi. The cells were stained with pp28 mAb (green), counterstained with
propidium iodide (red) and analyzed by confocal microscopy. A and B rows represent low and high magnifications, respectively. The white arrows point to the
cytoplasmic vacuoles in mutant-infected cells. The yellow arrow points to the nuclear vacuoles in mutant-infected cells. Nomarski images (C) are presented. (For
interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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differ between the wild type and the mutant virus in repeated
experiments (Fig. 2B). These results demonstrate that the
membrane association of pp28 is not dependent on functional
UL97.
Pharmacological inhibition of UL97 kinase in cells infected
with wt-HCMV results in a ΔUL97-like pp28 distribution
Our observations show that the deletion of UL97 results in
an abnormal distribution of pp28 in infected cells (Fig. 1). In
order to see if this effect is due to the lack of the kinase
activity of the UL97 gene product, we employed the
indolocarbazole NGIC-I, shown to inhibit the kinase activity
of the UL97 in vitro (Marschall et al., 2001). NGIC-I (0.5 μM)
was added to the growth medium following viral adsorption,and cells were further incubated in the presence of the drug for
96 h. Significantly, treatment of wt-HCMV-infected cells with
NGIC-I converted the pp28 compact subcellular distribution
into the ΔUL97 characteristic pattern (in 80% ± 6.7 of the
infected cells, Fig. 3). In addition, the nuclei lost the typical
kidney shape to assume a more round, regular shape. By
contrast, NGIC-I exerted no additional effects on either the
pp28 subcellular distribution or the nuclear shape in cells
infected with ΔUL97 (92% ± 4.7 diffuse forms, Fig. 3). Taken
together, these results strongly suggest that it is the lack of
UL97 kinase activity that causes the abnormal pp28 pattern in
cells infected with ΔUL97. This conclusion was further tested
in a kinetic block-release assay of NGIC-I. Cells were treated
for 96 h with this inhibitor and then released from the drug
block and examined 24 h, 48 h, 72 h and 96 h later. Viral yield
measurements indicated a two log reduction in wt-HCMV titer
Fig. 2. Membrane association analysis of pp28. (A) Flotation fractions (numbers at the bottom) of CHAPS extracts of cells infected with either wt-HCMV (AD169) or
with the mutant (ΔUL97) were collected from the top of Nycodenz gradient (1st—low density, 12th—high density) and subjected to Western blot analysis using
pp28 mAb (C and D). Flotation fractions of AD169 infected cells were also subjected to Western blot analysis using calnexin mAb (A) and fumarase mAb (B). (B)
Calculated percentage of pp28 in the different flotation fractions (1–12) of AD169 and ΔUL97-infected cells. The results were derived from 3 independent
experiments.
72 M. Azzeh et al. / Virology 354 (2006) 69–79following 96 h of drug treatment relative to non-treated
infected cells (103 versus 105 PFU/ml), while no effect of the
treatment was observed on the ΔUL97 viral yield (which
ranged between 5 × 102 and 103 PFU/ml in both untreated and
NGIC-I treated cells). Although NGIC-I is known to inhibit
other protein kinases, this further demonstrated a specific
inhibition of UL97 kinase by NGIC-I, under the indicated
concentration. Drug release of wt-HCMV-infected cells
resulted in a gradual reversal of pp28 subcellular distribution
to a wild-type-like phenotype, from 14% during block to 36%
and 54% at 24 h and 72 h after release, respectively (Fig. 3),
with resumption of wild type viral yield levels (1.5 × 105 PFU/
ml) at 72 h following release. While the proportion of compact
forms observed at 72 h following release was lower that that
observed in untreated wild-type-infected cells, it appearedsufficient for resumption of normal viral yield. The slow
morphological reversion could result from accumulation of
non-reversible “end products” in the absence of UL97 or from
delayed downstream effect of the release of an earlier block.
Tegument protein pp28 co-localizes with wheat germ
agglutinin (WGA) ligands in wild-type- and ΔUL97-infected
cells
Previous studies have localized pp28 to Golgi-related
structures of the secretory pathway (Sanchez et al., 2000a,
2000b). We thus examined whether the disparate pp28 patterns
in cells infected with wt-HCMV and ΔUL97 might reflect a
different organization of cellular organelles. To this end, we
probed cells with FITC-conjugated WGA, which binds to
Fig. 3. Cellular distribution of HCMV pp28 during NGIC-I block and following NGIC-I block-release. NGIC-I (0.5 μM) was added to AD169 or ΔUL97-infected
cells for 96 hpi (block). NGIC-I was washed out, and cells were analyzed at 24 h (24 hR) and 72 h (72 hR) following NGIC-I release. The cells were prepared and
analyzed as described in the legend to Fig. 1.
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acetylglucosamine-containing oligosaccharides on proteins
(Bhavanandan and Katlic, 1979) and decorates distal Golgi
cisternae, the trans-Golgi network and the cell surface (Tartak-
off and Vassalli, 1983; Virtanen et al., 1980).
In uninfected fibroblasts, WGA stained perinuclear struc-
tures that were reminiscent of the classical Golgi organization
(Fig. 4). The WGA staining was strikingly modified by viral
infection. First, the WGA staining intensity in both wt-HCMV
and ΔUL97-infected cells was much stronger than in
uninfected fibroblasts. Most interestingly, the WGA pattern
assumed either compact or diffuse shapes (Fig. 4) in wt-HCMV
(94% ± 1.5% compact) and ΔUL97-infected cells
(91% ± 2.5%) diffuse), respectively, similar to the patternsobserved for pp28 (Fig. 1). In particular, with ΔUL97, the
WGA-positive structures were punctuated by vacuoles of non-
reactive material similar to those found with pp28 (Fig. 1).
These observations suggested that (i) viral infection induces a
profound reorganization of WGA-positive structures (presum-
ably including Golgi membranes), and (ii) pp28 might co-
localize with these cellular structures.
To examine the latter point, we performed double staining
experiments (Fig. 5). Cells were infected with either virus for
96 h and then co-stained with WGA-FITC and with the mAb to
pp28 followed by an Alexa red 633-conjugated secondary Ab
(Fig. 5A). With both viruses, the two antigens significantly co-
localized. Strikingly, with ΔUL97 (RCΔ97.08 and RCΔ97.19
isolates), both pp28 and WGA distributions were punctuated by
Fig. 4. Distribution of WGA in HCMV-infected HF cells. Cells infected with AD169 or ΔUL97 viruses were examined at 96 hpi by confocal microscopy following
immunofluorescence staining with FITC-conjugated WGA. The upper and lower rows show untreated cells or cells treated with NGIC-I (0.5 μM) throughout the
infection period, respectively. Mock-infected cells served as a control. The white arrows point to the cytoplasmic vacuoles in NGIC-I treated AD169-infected cells.
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localization studies with pp28 and mannosidase II antibodies
(data not shown). These results are consistent with the idea that:
(i) pp28 positive Golgi structures are remodeled in the infected
cells and (ii) UL97 affects this Golgi redistribution.
To determine if this effect was due to the loss of UL97
kinase activity in ΔUL97, infected cells were treated with
NGIC-I. In cells infected with wt-HCMV, the WGA staining
assumed the readily recognizable diffuse pattern with vacuoles,
characteristic of the ΔUL97 mutant (91 ± 2% diffuse forms;
Fig. 4). In contrast, NGIC-I had no effect on the WGA pattern
in cells infected with the mutant strain (90% diffuse forms) nor
did it alter the general appearance of the WGA ligands in
mock-infected cells (Fig. 4). Thus, although NGIC-1 may
nonspecifically inhibit cellular kinases, the lack of effect in
mutant-infected and mock-infected cells supports the specific
association of UL97 kinase inhibition with the observed
phenotype.
Taken together, these results confirm that (i) there is a Golgi
remodeling in HCMV-infected cells and that (ii) the lack of viral
UL97 kinase activity is the primary cause for the characteristic
ΔUL97 Golgi pattern.
Subcellular distribution of the HCMV major glycoprotein and
its correlation to pp28
Previous studies have shown that the major viral glycoprotein
gB localizes to perinuclear Golgi structures in human fibroblasts
infected with wt-HCMV (Sanchez et al., 2000a, 2000b). To
examine if the virus-induced reorganization of Golgi mem-branes is also reflected in the localization of gB, cells infected
with either viral strain were co-stained with a gB mAb and with
WGA-FITC (Fig. 5B). In most cells, these two antigens co-
localized almost completely. In particular, gB stained the rims of
the abundant vacuoles seen in cells infected with ΔUL97.
These results suggest that pp28 and gB proteins in both wild
type and mutant HCMV-infected cells localize to modified
compartments of the secretory pathway which may include the
Golgi apparatus as well as related structures. UL97 kinase
appears to be required for the viral-induced modification of the
cellular secretory pathway.
The modified subcellular distribution of pp28 and WGA in
ΔUL97-infected cells does not result from impaired DNA
synthesis or encapsidation
We have previously reported thatΔUL97 mutant synthesizes
4 to 6 times less viral DNA than the wild type virus with several
fold reduction in late protein accumulation and exhibits a defect
in DNA encapsidation (Wolf et al., 2001). To examine whether
any of these effects (on DNA synthesis and encapsidation and
late protein expression) could nonspecifically lead to the
assembly sites phenotype observed in the absence of UL97,
infected cells were treated with either the DNA polymerase
inhibitor PFA or the cleavage-packaging inhibitor BDCRB
(20 μM) (Fig 6). The PFA concentration for the comparative
experiments was selected following incubation of wild-type-
infected cells with different PFA concentrations ranging from 1
to 300 μg/ml. The selected concentration (30 μg/ml) was the
one which reduced wild type DNA synthesis by 3- to 5-fold to a
Fig. 5. Co-localization of viral structural proteins with WGA. HF cells were infected with either AD169 or ΔUL97 viruses. At 96 hpi, cells were fixed, stained with
mAbs to either pp28 (A) or gB (B), both shown in red, co-stained with WGA-FITC (green) and analyzed by confocal microscopy.
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experiments, as measured by real time PCR of infected cells.
When mutant-infected cells were treated with similar PFA
concentration, DNA accumulation was reduced by 2-fold. As
expected, an early block in viral replication by PFA reduced the
synthesis of pp28 to a varying degree in different experiments.pp28 distribution assumed a weak compact or partially diffuse
pattern in treated wild-type-infected cells (Fig 6). This pattern
was completely different from that observed upon inhibition of
UL97, despite comparable levels of DNA and protein
expression. Of note, in the presence of PFA, the nuclei
maintained the spherical shape, observed in uninfected cells.
Fig. 6. Cellular distribution of HCMV pp28 in BDCRB and PFA treated infected cells. Either BDCRB (20 μM) or PFA (30 μg/ml) was added to AD169 or ΔUL97-
infected cells or to mock-infected cells for 96 hpi. Drug-treated infected cells were stained with pp28 mAb, while drug-treated mock-infected cells (shown in the Mock
panels) were stained with FITC-conjugated WGA. Cells were counterstained with propidium iodide (red). (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)
76 M. Azzeh et al. / Virology 354 (2006) 69–79BDCRB block resulted in inhibition of DNA cleavage and
encapsidation with abrogation of virus replication in both wild-
type- and mutant-infected cells, without inhibition of virus
DNA synthesis or late protein expression (data not shown)
(Wolf et al., 2001). No effect of BDCRB on pp28 subcellular
distribution was observed following infection with either wild
type or mutant virus (Fig. 6). These results suggest that the
unique morphology of viral cytoplasmic assembly sites formed
in the absence of UL97 is not simply a consequence of early or
late block in the replication cycle but is rather more specifically
related to a deficiency of UL97 kinase activity.
Discussion
Previous studies have shown that the HCMV UL97 kinase
plays a major role in early and late nuclear phases of the viral
life cycle including DNA replication and encapsidation and
nuclear egress (Biron et al., 2002; Krosky et al., 2003a, 2003b;
Wolf et al., 2001). In this study, we reveal a novel involvement
of UL97 kinase in the distribution of the viral cytoplasmic
assembly sites and in the remodeling of Golgi structures during
HCMV infection.
The distribution of viral cytoplasmic assembly sites is modified
in the absence of UL97 kinase activity
In cells infected with wt-HCMV, several structural proteins
including pp28 congregate into compact, juxtanuclear struc-tures that appear to impact on the nucleus (Fig. 1). Our results
suggest that the UL97 kinase activity is required for the
formation of these compact assembly sites. When this activity
was abrogated either by deleting the UL97 gene or by using
the kinase inhibitor NGIC-I, the pp28-containing compact
structures were replaced by more diffuse perinuclear struc-
tures. Importantly, this altered distribution was punctuated by
large cytoplasmic vacuoles, with peripheral pp28 staining.
Similar changes were found in the cellular localization of the
tegument protein pp65, which also stained the rims of
intranuclear vacuoles (data not shown) and of the envelope
glycoprotein gB (Fig. 5), thus reflecting a general modifica-
tion in the assembly sites of viral structural proteins in the
absence of active UL97 kinase. Interestingly, Prichard et al.
have recently characterized the formation of similar nuclear
vacuoles in the absence of UL97 kinase as aberrant
aggregates of viral structural proteins, composed predomi-
nantly of pp65 (Prichard et al., 2005). Together, the combined
findings argue for a defect in nuclear and cytoplasmic steps of
tegument trafficking and assembly upon inhibition of UL97
function.
pp28 membrane association is not affected by UL97
The proper intracellular trafficking of pp28 and its
membrane association (via a myristic acid moiety) are required
for HCMV secondary envelopment (Jones and Lee, 2004;
Sanchez et al., 2000a, 2000b; Silva et al., 2003). Although the
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association of pp28 could promote the budding of partially
tegumented nucleocapsids into cytoplasmic vacuoles or serve in
the bridging of the tegument to membrane-associated glycoli-
pids during assembly. The anomalous cellular localization of
pp28 observed with the ΔUL97 mutant initially suggested that
UL97 could affect the membrane association of pp28. However,
our CHAPS flotation results indicate that membrane association
of pp28 does not depend on functional UL97 (Fig. 2).
Deficiency of UL97 kinase activity affects the remodeling of
cellular structures during HCMV infection
Infection of cells with wt-HCMV significantly alters the
morphology of the cellular secretory pathway, as reflected by
the modified distribution of WGA ligands (which label
primarily the trans-most sites of the Golgi (Tartakoff and
Vassalli, 1983; Virtanen et al., 1980) (Fig. 4). Most noticeably,
Golgi structures and viral assembly sites are compacted together
at the centrosomal region by microtubule-dependent mechan-
isms (Sanchez et al., 2000a, 2000b). The importance of this
redistribution for the viral life cycle, and the mechanisms that
lead to it, has not yet been established. However, this finding is
consistent with the utilization of a Golgi-derived compartment
by HCMV for final envelopment (Homman-Loudiyi et al.,
2003; Mettenleiter, 2002; Sanchez et al., 2000a, 2000b). One of
the most dramatic effects of UL97 kinase abrogation, observed
here, is that the viral-induced Golgi pattern is markedly different
from that induced by the wild type virus. Importantly, the viral
structural proteins pp28 and gB still co-localized with the Golgi
in cells infected with the ΔUL97 mutant (Fig. 5). We conclude
that the UL97 kinase is required for the proper reorganization of
the Golgi by HCMV. By contrast, it is not required for the
association of the viral assembly sites with Golgi elements.
An effect of UL97 kinase deletion on the shape of the nuclei
in infected cells was also observed. In cells infected with wt-
HCMV, the nuclei assume a kidney shape and seem to be
impacted by the compact Golgi-related viral assembly site. This
can be seen in Fig. 1, as well as in the work of other
investigators (Sanchez et al., 2000a, 2000b). In the absence of
UL97 activity, the nuclei maintained their spherical shape (Figs.
1 and 3). This failure to rearrange the nucleus could indirectly
result from inhibition of early replication steps, similar to the
effect observed with PFA treatment (Fig. 6), however, it could
also be related to the recently reported role of UL97 in
phosphorylation and redistribution of nuclear lamina compo-
nents (Marschall et al., 2005). As has been shown for murine
CMV, reduced phosphorylation and dissolution of the nuclear
lamina could account for the impairment in nuclear cytoplasmic
egress found in the ΔUL97 mutant (Muranyi et al., 2002;
Krosky et al., 2003a).
How could the UL97 kinase affect the organization of
cytoplasmic assembly sites?
UL97 kinase has been shown to mediate several events
during the nuclear phase of viral replication. The observedcytoplasmic structural changes could potentially result from the
nuclear effects, including the failure of the ΔUL97 mutants to
remodel the nuclear lamina and rearrange the nucleus,
combined with reduced assembly and export of nuclear particles
to the cytoplasmic sites. However, antiviral pharmacologic
inhibition of replication and assembly did not exert the
assembly site pattern observed in the absence of UL97 kinase.
While these experiments have not ruled out that the observed
cytoplasmic effects are due to the role of UL97 in nuclear
egress, our findings link the phenotype to specific UL97 kinase
activity and raise the question of whether UL97 kinase might
contribute directly to organization of the cytoplasmic assembly
sites. In cells infected with wt-HCMV, Golgi elements
accumulate strictly at the centrosome (Sanchez et al., 2000a).
This suggests that viral infection either exaggerates the coupling
of the Golgi with microtubuli or alters the microtubule
cytoskeleton. UL97 kinase could act directly on cellular targets
to induce these events. Direct alteration of Golgi morphology by
UL97 could be exerted by phosphorylation of one or more of its
structural component/s. Phosphorylation of Golgi structural
proteins has been linked to morphological changes that take
place during Golgi disassembly at mitosis (Lowe et al., 2000)
and may occur during viral infection and enhance cytoplasmic
transport.
Yet, the gradual reversion of the assembly site distribution
following NGIC-I block-release appears more consistent with
earlier biosynthetic inhibitions, having downstream effects on
the cytoplasmic remodeling events. In this regard, we favor the
possibility that the gross morphological changes recently found
in the distribution of tegument proteins in the nucleus upon
reduction of UL97 kinase activity (Prichard et al., 2005) could
be interlinked with the reorganization of the cytoplasmic
assembly sites of viral structural proteins.
Despite the critical functions ascribed to the UL97 kinase in
nuclear events of virion assembly and egress, its absence results
in partial replication defect, and its major impact on specific
viral replication steps varies in different cellular systems and
growth conditions (Biron et al., 2002; Krosky et al., 2003a;
Wolf et al., 2001), suggesting dynamic interaction with cellular
components and complementation by host cell kinases. Here,
we propose that UL97 kinase may also be required for later
cytoplasmic steps of viral replication, involving the formation
of assembly sites. Thus far, the sequence of tegument protein
acquisition and trafficking during virion assembly has remained
unknown. The studies of the UL97 kinase function could
identify connections between nuclear and cytoplasmic steps of
tegumentation and shed light on protein interactions mediating
the organization of the host cell secretory pathway during
infection.
Materials and methods
Cells, viruses, antibodies and drugs
HCMV strain AD169 (wt-HCMV; American Type Culture
Collection) and the UL97 deletion mutants RCΔ97.08 and
RCΔ97.19 (ΔUL97; Prichard et al., 1999) were propagated in
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et al., 2001). Primary mouse monoclonal antibodies (mAbs)
against HCMV pp28, pp65 and glycoprotein B (gB) were
purchased from Rumbaugh-Goodwin Institute (Plantation,
Florida, USA). The secondary antibodies were Alexa Fluor
633 goat anti-mouse IgG (Molecular probes, OR, USA) and
fluorescein anti-mouse IgG (Vector, Burlingame, CA, USA).
All secondary antibodies are highly cross-absorbed. Wheat
germ agglutinin (WGA) coupled to fluorescein isothiocyanate
(FITC) was obtained from Sigma (St. Louis, Missouri, USA).
The antiviral drugs BDCRB (20 μM, a kind gift from John
Drach, University of Michigan) or NGIC-I (0.5 μM, Calbio-
chem, Germany) or phosphonoformate (PFA) (30 μg/ml;
Sigma) were added after a 1 h period of virus adsorption to
cells that were incubated in the presence of the drug for 96 h
post infection (pi). For block-release experiments, cultures were
washed five times with PBS and then further incubated for the
indicated times post drug release in drug-free medium.
Immunofluorescence assay
Cells grown on 8-well glass slides (Labtek chamber slide w/
cover, #177402, Nalge Nunc International, Naperville, IL
60563) were infected at a multiplicity of infection (moi) of
0.5 PFU/cell, unless otherwise indicated. Supernatant was
removed at 96 h pi, and cells were washed 3 times with PBS and
fixed with 3.7% formaldehyde (Sigma Aldrich) for 30 min at
room temperature. Cells were washed 5 times with PBS + 1%
NH4Cl, permeabilized by 0.1% TX100 for 5 min and washed 5
times with PBS + 1% NH4Cl. After 1 h of blocking using 1%
BSA in PBS, the indicated primary antibody was added to the
cells in appropriate dilution in 0.5% BSA in PBS and incubated
either at room temperature for 2 h or overnight at 4 °C. The
secondary antibody was added to the cells in appropriate
dilution in PBS containing 0.5% BSA for 30 min at room
temperature and washed by PBS. For co-localization studies,
WGA-FITC was added with the secondary antibody. Following
mounting in 5% n-propyl gallate, 100 mM Tris–HCL, pH 9,
70% glycerol (Giloh and Sedat, 1982), the cells were analyzed
by confocal microscopy (Zeiss Axiovert 135 M, Germany).
Results were monitored on at least 3 independent experiments,
scoring between 300 and 400 cells.
CHAPS flotation assay
HF (5 × 106 cells) infected with either AD169 or ΔUL97
viruses at an moi of 0.05 were harvested at 6 days pi, washed
and incubated for 10 min at 4 °C in cold PBS. Cells were
then scraped and pelleted for 10 min at 4 °C, 3000 rpm,
1000 gav. The cell pellet was re-suspended in 550 μl TNE-
CHAPS lysis buffer (25 mM Tris, pH 7.5, 150 mM NaCl,
5 mM EDTA + 1% CHAPS) and incubated for 30 min at 4
°C (on ice) followed by 5 min sedimentation at 4 °C,
3000 rpm. The supernatant (450 μl) was transferred to pre-
cooled 2 ml Beckman ultracentrifuge tube and mixed gently
with 450 μl cold 70% Nycodenz in TNE. The gradient was
then built by loading the tubes with 200 μl of decreasingNycodenz concentrations: 25, 22.5, 20, 18, 15, 12 and 8%.
Following centrifugation in TLS55 Beckman rotor for 3 h,
55,000 rpm, 260,000 gav, 4 °C, without break, twelve 180 μl
fractions were removed, starting from the top of the gradient,
and analyzed by Western blot using the ECL detection
method.
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